FDA-approved drug kills cancer cells in lab by disrupting cellular recycling
Researchers from VCU Massey Comprehensive Cancer Center recently demonstrated that the inhibition of glucosylceramide synthase (GCS) can cause death in cancer cells that is independent of changes in pro-death ceramide levels. ...
Nov 9, 2026
0
16









